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Nanofocused synchrotron X-ray absorption
studies of the intracellular redox state of an
organometallic complex in cancer cells†
Carlos Sanchez-Cano, ‡§*a Diego Gianolio,‡b Isolda Romero-Canelon, ¶a
Remi Tucoulouc and Peter J. Sadler *a
Synchrotron nanoprobe X-ray absorption (XAS) studies of a potent
organo-osmium arene anticancer complex in ovarian cancer cells
at subcellular resolution allow detection and quantification of both
OsII and OsIII species, which are distributed heterogeneously in
diﬀerent areas of the cells.
The rich chemistry of transition metals allows them to undergo
a wide variety of reactions inside cells.1 Novel metallodrugs can be
designed which reach diverse cellular targets and have unusual
eﬀects on biochemical pathways.2 They oﬀer a new strategy to help
overcome tumour resistance to chemotherapy, a current clinical
need.3 However, elucidation of the eﬀects of metallodrugs on
biomolecular interactions in cells is a major challenge.4
The organometallic osmium half-sandwich, ‘piano-stool’
complex [(Z6-p-cym)Os(Azpy-NMe2)I]
+ (p-cym = p-cymene, Azpy-
NMe2 = 2-(p-((dimethylamino)phenylazo)pyridine)) [1] (Fig. 1a)
is a promising anticancer drug candidate with interesting
anticancer activity in vitro and in vivo.5 The osmium complex
penetrates readily into the core of tumours,6 has a diﬀerent
mechanism of action from cisplatin and is capable of over-
coming platinum resistance.5 Complex 1 is a relatively inert
prodrug that is activated by hydrolysis of the Os–I bond in a
reducing environment inside cells,7 and rapidly generates ROS
efficiently through mitochondrial pathways.8 In vitro experiments
have shown that the reaction between 1 and GSH generates reactive
analogues, including the hydroxido and chlorido complexes 1-OH
or 1-Cl, respectively, which can bind to cysteine residues and
generate OH radicals in the presence of hydrogen peroxide
(Scheme S1, ESI†).7 However, the nature of the derivatives of 1
involved in the cellular activity of the drug after intracellular
activation is not understood. Here we use X-ray absorption
spectroscopy (XAS) to investigate the chemical behaviour of 1 in
cancer cells.
Synchrotron radiation is particularly suitable for exploring
the chemical behaviour of metals in biological samples.9 XAS is
a powerful technique that can be used to obtain valuable
information about the chemical state, and the electronic and
structural properties of metals. This is achieved by using an
X-ray beam of variable energy to probe the binding energy of
electrons in specific electronic shells of the element (X-ray
Absorption Near Edge Structure; XANES), or the elastic scattering
processes between the photo-electrons generated by the incident
beam and other atoms in the vicinity of the metal centre (Extended
X-Ray Absorption Fine Structure, EXAFS) (Fig. S1, ESI†). The study of
bulk cell populations (e.g. cell pellets or tissue samples)10 and single
cells (by using microprobe beamlines)11 with these techniques has
provided information on the oxidation state and speciation of
several metallodrugs. Furthermore, state-of-the-art nanofocused
synchrotron radiation allows imaging and spectroscopic techniques
to be combined in studies of metal systems with subcellular
resolution. However, although nano-XAS has allowed the chemical
characterisation of nanomaterials with nanometre resolution,12
sensitivity limits of the technique usually hamper its application
for studies of metals inside cells.
To record meaningful XAS spectra using nanofocused syn-
chrotron radiation, a metallodrug needs to be (1) present in
high concentration inside cells (diﬃcult to achieve when using
biologically-relevant doses), or (2) concentrated within small
specific areas of the cell. Recent X-ray fluorescence (XRF) maps
of cells treated with 1 show a marked concentration of osmium
within small organelles (probably mitochondria; supported by
ICP-MS analysis of mitochondrial fractions extracted from the
same cells).13 Hence, we have investigated nano-XAS spectra of
the Os L-edge in cells treated with 1 to provide new insight into
its intracellular speciation.
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We used hard X-rays (over 5–10 keV) focused on a 70 
100 nm2 spot size at the nano-analysis beamline ID16B14
(ESRF) to record XAS spectra on selected areas of A2870 ovarian
carcinoma cells treated for 24 h with 1 mM of 1. Both 500 nm
thick sections of epon embedded cells [TS] and whole cells cryo-
fixed and then dehydrated [CFD] were studied.
This comparison was made to rule out the possibility that
sample preparation for sections might aﬀect the chemical form
of 1 in cells. Initially, XRF maps were collected to detect areas
with high concentrations of Os. As observed previously,13 peaks
corresponding to emissions resulting from excitation of the
Os–L, Zn–K and Cu–K edges were observed for samples treated
with 1 (Fig. S1 and S2, ESI†), independently of the sample
fixation protocol used. XRF elemental maps confirmed that Os
was highly concentrated in small areas within the cytoplasm of
cells, and not in the nuclei, the latter regions being where high
concentrations of Zn were found (Fig. 1 and Fig. S3, S4, ESI)†.
Nano-XAS Os L3-edge spectra (probing 2p3/2 electrons;
Fig. S1, ESI†) were recorded at ambient temperature for areas
where XRFmaps showed a high density of Os (red boxes in Fig. 1b,
c and Fig. S3, S4, ESI†). The spectra displayed well-defined XANES
and short EXAFS regions where some fine structures could be
observed (Fig. 2a and Fig. S5, ESI†). The XAS spectra were recorded
for a series of OsII standards that might represent species that
could be found inside cells, based on the in vitro activation
experiments (1, 1-OH, 1-Cl and 1-SG; Scheme S1 and Fig. S6,
ESI†),7 but also Os0 to OsIV standards to probe the oxidation
state of intracellular Os species. Where possible, the S/N ratios
were improved by averaging multiple scans obtained on each
area (Table 1). Small drifts in the position of the beam were
observed between individual acquisitions. This was compensated
for by realigning the beam before each scan, but ultimately
implied that the spatial resolution of the XAS measurements
was slightly worse than the 70  100 nm2 spot size. Data analysis
is complicated for Os L-edges due to the large atomic size and
atomic number of Os.15 Remarkably, the ranges of energy of the
incident X-rays used for obtaining the XAS spectra and wave-
number k (Å1) are related, and define the resolution for the
measurement of interatomic distances between the metal and its
coordination sphere. The longer these ranges are, the higher is
the precision of the calculation on the length of these bonds. We
were able to collect meaningful EXAFS only for wavenumbers up
to k = 8 Å1 (Fig. S5c and d, ESI†), which proved to be too small to
provide highly accurate information on the coordination sphere
of the complex. Through XANES analysis it was also impossible to
diﬀerentiate between 1 and its derivatives (i.e. 1-OH, 1-Cl, etc.;
Fig. S6, ESI†), and therefore the speciation of 1 inside cells could
not be fully determined.
Nonetheless, XANES spectra of Os standards with oxidation
states between 0 and IV+ were significantly diﬀerent (Fig. 2b
and Fig. S7, ESI†). The small diﬀerences between the XANES of
1 and its analogues (Fig. S6, ESI†) suggest that changes
observed for Os0 to OsIV standards should be mainly related
to the oxidation state of the metal centers, and not to possible
contributions from their coordination sphere. Interestingly, the
spectra obtained from areas within cells appeared to be inter-
mediate between OsII and OsIII by comparison with standards
(Fig. 2c and Fig. S8–S16, ESI†). Moreover, Linear Combination
Fig. 1 (a) Structures of [(Z6-p-cym)Os(Azpy-NMe2)I]
+ [1] and substitution products. XRF maps showing the cellular distribution of Os and Zn in (b) cryo-
fixed and dehydrated A2780 cells (CFD), and (c) 500 nm thick sections of A2780 cells (TS), treated for 24 h with 1 mM 1. The red squares and white
numbers indicate areas where nano-XAS spectra were recorded. Energy settings: 11.2 keV, flux 5  108 ph s1. Raster scan: 100 100 nm2 step size, at 1 s
dwell time.
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Fitting (LCF, using the OsII and OsIII standards) revealed high
spatial heterogeneity, with different contributions of OsII and
OsIII oxidation states to the multiple spectra recorded (even
when the areas studied were found within the same cell, Fig. 1,
Table 1 and Fig. S4, ESI†). Between 0–30% OsII and 100–70% OsIII
species were found in the different areas analysed (Table 1).
However, the overall ratio of OsII/OsIII species found in each
sample was constant and independent of the fixation method
used (ca. 10% OsII and 90% OsIII; Fig. 2d). Unfortunately, con-
tinuous irradiation of a solid sample of 1 for over 30 min using a
microfocused beam with a similar flux density to the one used in
our studies suggested that beam damage could cause some of the
oxidation observed (Fig. S17, ESI†). The XRF elemental mapping
involved irradiation of the samples for much shorter times (dwell
time 1 s), avoiding unwanted oxidation. A higher number of scans
improved the S/N ratios, but, in CFD samples, the irradiation time
also appeared to correlate with observation of increasing quantities
of OsIII in the areas studied (as calculated by LCF from standards;
Table 1 and Fig. S18, ESI†). For sectioned cells (TS), in contrast, the
relative quantities of OsII and OsIII species were related to the spatial
localisation of the cellular area studied, and not to the number of
scans obtained (Fig. 3, Table 1 and Fig. S18, S19, ESI†). It was not
possible to assess this on CFD samples since we analysed only one
area per cell. Hence we cannot rule out the possibility that some
beam damage might have occurred when multiple scans were
obtained from individual areas of the cells (to improve the S/N ratio
of XANES spectra). Nevertheless, this beam damage is not
responsible for the differences observed in the speciation of
Os, which is related to cellular localisation.
Overall, these studies show that meaningful nano-XAS spec-
tra can be obtained from ovarian cancer cells treated with
biologically-relevant concentrations of an Os-based candidate
anticancer drug. Although no information on the coordination
sphere of the complex could be obtained, a heterogeneous
distribution of OsII and OsIII species within the treated A2780
cells was observed. Such spatial variations in the speciation of
the drug are interesting, and might be due to the presence of:
(1) diﬀerent degrees of oxidation of 1 within the areas studied,
or (2) an intracellular redox cycle as part of the mechanism of
Fig. 2 (a) XANES spectra collected from areas with high densities of Os in cryo-fixed and dehydrated (CFD) or 500 nm thick sections (TS) of A2780 cells,
treated for 24 h with 1 mM 1; (b) XANES spectra of Os standards: Os powder (Os0), 1 (OsII), OsCl3 (Os
III) and [NH4]2OsCl6 (Os
IV) (c) XANES spectra of 1 (OsII)
and OsCl3 (Os
III) standards, and spectra collected in positions CFD-1 and TS-5 (green and red dotted lines show maximum of secondary peaks for OsII
and OsIII standards); and (d) average ratio of OsII and OsIII species found in CFD and TS samples. Scan: 10.82–11.12 keV; 1 eV step; 3 s accumulation; and
70  100 nm2 beam size.
Table 1 Number of scans per sample and ratios of OsII and OsIII species
on areas of cryo-fixed and dehydrated (CFD) or 500 nm thick section (TS)
cells, calculated as LCF from standards
Sample Scans OsII OsIII Error R-factor
CFD-1 40 0.04 0.96 0.05 0.0019
CFD-2 8 0.20 0.82 0.10 0.0041
TS-1 2 0.28 0.72 0.15 0.0117
TS-2 3 0.00 1.00 0.10 0.0099
TS-3 10 0.00 1.00 0.12 0.0122
TS-4 10 0.19 0.81 0.13 0.0261
TS-5 15 0.00 1.00 0.09 0.0467
TS-6 4 0.00 1.00 0.08 0.0061
TS-7 4 0.18 0.82 0.09 0.0075
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action of the drug. Remarkably, biometals such as Fe and Cu
can generate OH radicals inside cells in the presence of H2O2
through redox-dependent reactions.16 A similar redox cycle
involving OsII/OsIII species could explain the ROS increase
observed when cells are treated with 1. However, additional
experiments are needed to fully understand the mechanism
responsible for the intracellular generation of OsIII species, and
its importance in the anticancer mechanism of action of 1.
XRF and XAS were obtained in the frame of the ESRF
proposal CH-4714. We thank Dr Tina Geraki (I18, Diamond
light source) for help with beam damage measurements, the
CRUK/EPSRC (Grant No. C53561/A19933), the EPSRC (Grant
No. EP/F034210/1) and the Wellcome Trust (Grant No. 107691/
Z/15/Z) for financial support.
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